Vericel (VCEL) Earnings Date & Reports

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

VCEL is expected to report earnings to rise 98.25% to 7 cents per share on November 11

Q3'26

Est.

$0.08

Q2'26

Beat

by $0.07

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.06

Q3'25

Beat

by $0.11

The last earnings report on July 30 showed earnings per share of 3 cents, beating the estimate of -2 cents. With 260.39K shares outstanding, the current market capitalization sits at 2.35B.

View a ticker or compare two or three

VCEL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days